BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21524464)

  • 1. Invited commentary.
    Wee JO; Colson YL
    Ann Thorac Surg; 2011 May; 91(5):1538. PubMed ID: 21524464
    [No Abstract]   [Full Text] [Related]  

  • 2. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yang HX; Luo RZ; Zhang Y; Li M; Wang X; Jia WH
    Ann Thorac Surg; 2011 May; 91(5):1531-8. PubMed ID: 21524463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
    J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthoracic vs. transhiatal esophagectomy: Stage migration muddies the water.
    Block MI
    J Surg Oncol; 2006 Jun; 93(7):519-20. PubMed ID: 16705733
    [No Abstract]   [Full Text] [Related]  

  • 5. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
    Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
    Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An audit of surgical outcomes of esophageal squamous cell carcinoma.
    Goan YG; Chang HC; Hsu HK; Chou YP
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited commentary.
    LoCicero J
    Ann Thorac Surg; 2008 Jun; 85(6):1946. PubMed ID: 18498799
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
    Yuequan J; Shifeng C; Bing Z
    Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy after esophagectomy: ripe for a randomized trial.
    Jiwnani S; Karimundackal G; Pramesh CS; Laskar SG
    Ann Thorac Surg; 2011 May; 91(5):1652. PubMed ID: 21524496
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
    Hummel R; Hussey DJ; Michael MZ; Haier J; Bruewer M; Senninger N; Watson DI
    Ann Surg Oncol; 2011 Jan; 18(1):253-60. PubMed ID: 20628822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transhiatal esophagectomy for squamous cell carcinoma in liver transplant recipients.
    Meneu-Diaz JC; Moreno-Gonzalez E; Garcia I; Moreno-Elola A; Jimenez C; Calvo Pulido J; Hidalgo Pascual M; Perez Saborido B; Jimenez Galanes S; Fundora Suarez Y; Marques E
    Hepatogastroenterology; 2008; 55(86-87):1738-41. PubMed ID: 19102381
    [No Abstract]   [Full Text] [Related]  

  • 16. Transhiatal versus transthoracic esophagectomy for clinical stage I esophageal carcinoma.
    Berdejo L
    Hepatogastroenterology; 1995; 42(6):789-91. PubMed ID: 8847024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
    Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
    Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous carcinoma of the mid-esophagus. A survival study.
    Harvey JC; Davidson W; Frankl H; Sachs T; Kagan AR
    Am Surg; 1991 Oct; 57(10):615-7. PubMed ID: 1718194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.